TY - JOUR T1 - Estimating dates of origin and end of COVID-19 epidemics JF - medRxiv DO - 10.1101/2021.01.19.21250080 SP - 2021.01.19.21250080 AU - Thomas Beneteau AU - Baptiste Elie AU - Mircea T. Sofonea AU - Samuel Alizon Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/26/2021.01.19.21250080.abstract N2 - Estimating the date at which an epidemic started in a country and the date at which it can end depending on interventions intensity are important to guide public health responses. Both are potentially shaped by similar factors including stochasticity (due to small population sizes), superspreading events, and ‘memory effects’ (the fact that the occurrence of some events, e.g. recovering from an infection, depend on the past, e.g. the number of days since the infection). Focusing on COVID-19 epidemics, we develop and analyse mathematical models to explore how these three factors may affect early and final epidemic dynamics. Regarding the date of origin, we find limited effects on the mean estimates, but strong effects on their variances. Regarding the date of extinction following lockdown onset, mean values decrease with stochasticity or with the presence of superspreading events. These results underline the importance of accounting for heterogeneity in infection history and transmission patterns to accurately capture early and late epidemic dynamics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThomas Beneteau is supported by a doctoral grant from the Ligue Contre le Cancer. Baptiste Elie was funded by the ENS Paris-Saclay.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was not subject to the IRB oversight.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCodes and results are available on gitlab. https://gitlab.in2p3.fr/ete/origin-end-covid-19-epidemics ER -